HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Roberto Gambari Selected Research

Plicamycin

1/2015Increase of microRNA-210, decrease of raptor gene expression and alteration of mammalian target of rapamycin regulated proteins following mithramycin treatment of human erythroid cells.
1/2012Mithramycin encapsulated in polymeric micelles by microfluidic technology as novel therapeutic protocol for beta-thalassemia.
9/2003Accumulation of gamma-globin mRNA in human erythroid cells treated with angelicin.
8/2003Mithramycin induces fetal hemoglobin production in normal and thalassemic human erythroid precursor cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Roberto Gambari Research Topics

Disease

57Neoplasms (Cancer)
05/2022 - 10/2002
41Cystic Fibrosis (Mucoviscidosis)
01/2022 - 01/2004
31Thalassemia
03/2022 - 01/2004
14Breast Neoplasms (Breast Cancer)
11/2014 - 10/2002
13Hepatocellular Carcinoma (Hepatoma)
10/2018 - 01/2005
12Infections
03/2022 - 06/2007
11Inflammation (Inflammations)
01/2022 - 01/2005
11Glioma (Gliomas)
08/2021 - 05/2014
11Sickle Cell Anemia (Hemoglobin S Disease)
10/2020 - 09/2003
11beta-Thalassemia (Cooley's Anemia)
04/2016 - 08/2003
8Leukemia
12/2015 - 09/2003
8BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
10/2013 - 01/2009
7Glioblastoma (Glioblastoma Multiforme)
05/2022 - 08/2015
7Pneumonia (Pneumonitis)
01/2016 - 05/2007
7Carcinoma (Carcinomatosis)
01/2014 - 04/2006
6Inborn Genetic Diseases (Disease, Hereditary)
03/2022 - 12/2013
6Hemoglobinopathies
03/2022 - 11/2009
5Psoriasis (Pustulosis Palmaris et Plantaris)
01/2019 - 09/2003
4Colorectal Neoplasms (Colorectal Cancer)
08/2020 - 09/2004
4Neoplasm Metastasis (Metastasis)
01/2020 - 10/2002
4Skin Diseases (Skin Disease)
10/2009 - 09/2003
3COVID-19
12/2021 - 01/2021
3Cytokine Release Syndrome
12/2021 - 01/2021
3Bacterial Infections (Bacterial Infection)
01/2020 - 01/2012
3Melanoma (Melanoma, Malignant)
03/2018 - 01/2005
3Anemia
05/2016 - 11/2009
3Hematologic Diseases (Blood Diseases)
01/2015 - 02/2012
2Human Influenza (Influenza)
03/2022 - 08/2009
2Neuroblastoma
01/2021 - 05/2016
2Lung Diseases (Lung Disease)
10/2018 - 11/2016
2Pseudomonas Infections
10/2018 - 12/2010
2Hypoxia (Hypoxemia)
01/2018 - 12/2011
2Fibrosis (Cirrhosis)
01/2016 - 09/2008
2Acute Erythroblastic Leukemia (Erythroleukemia)
01/2015 - 10/2009

Drug/Important Bio-Agent (IBA)

32MicroRNAs (MicroRNA)IBA
05/2022 - 01/2009
26GlobinsIBA
01/2022 - 01/2008
23Fetal Hemoglobin (Hemoglobin F)IBA
01/2022 - 08/2003
23Interleukin-8 (Interleukin 8)IBA
07/2021 - 05/2007
21Proteins (Proteins, Gene)FDA Link
12/2021 - 09/2004
19Messenger RNA (mRNA)IBA
01/2022 - 08/2003
18DNA (Deoxyribonucleic Acid)IBA
10/2018 - 01/2003
17Pharmaceutical PreparationsIBA
01/2022 - 02/2003
15Hemoglobins (Hemoglobin)IBA
12/2021 - 11/2009
14Biological ProductsIBA
12/2021 - 06/2009
13Peptide Nucleic AcidsIBA
02/2022 - 01/2004
13CytokinesIBA
12/2021 - 05/2007
12ChemokinesIBA
12/2021 - 05/2007
10NF-kappa B (NF-kB)IBA
01/2021 - 10/2002
9Transcription Factors (Transcription Factor)IBA
10/2013 - 10/2002
7Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA
01/2022 - 05/2007
6Interleukin-6 (Interleukin 6)IBA
07/2021 - 06/2007
6Temozolomide (Temodar)FDA LinkGeneric
11/2020 - 08/2015
5Furocoumarins (Furanocoumarins)IBA
12/2010 - 09/2003
4Reactive Oxygen Species (Oxygen Radicals)IBA
01/2020 - 12/2009
4corilaginIBA
10/2018 - 12/2010
4AntioxidantsIBA
03/2018 - 02/2006
4Codon (Codons)IBA
01/2018 - 01/2008
4beta-Globins (beta Globin)IBA
05/2016 - 01/2004
4PlicamycinFDA Link
01/2015 - 08/2003
4Peptides (Polypeptides)IBA
10/2014 - 01/2012
4gamma-GlobinsIBA
10/2009 - 08/2003
4Photosensitizing Agents (Photosensitizers)IBA
10/2009 - 09/2003
4Estrogen Receptor alphaIBA
06/2007 - 10/2002
3RNA (Ribonucleic Acid)IBA
01/2021 - 01/2012
3Caspase 3 (Caspase-3)IBA
01/2021 - 12/2005
3SuspensionsIBA
11/2020 - 09/2010
3Doxorubicin (Adriamycin)FDA LinkGeneric
10/2018 - 05/2014
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2016 - 11/2006
3OligodeoxyribonucleotidesIBA
01/2015 - 12/2010
31-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA
10/2013 - 02/2003
35-MethoxypsoralenIBA
04/2011 - 11/2009
3OxidesIBA
11/2010 - 02/2006
2Sirolimus (Rapamycin)FDA Link
03/2022 - 01/2022
2sulforaphaneIBA
02/2022 - 01/2020
2ChloridesIBA
01/2022 - 05/2014
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
12/2021 - 07/2021
2pyridineIBA
08/2021 - 04/2020
2Cell-Free Nucleic AcidsIBA
08/2020 - 10/2018
2TubulinIBA
04/2020 - 09/2008
2LigandsIBA
10/2019 - 10/2018
23- (4,5- dimethylthiazol- 2- yl)- 5- (3- carboxymethoxyphenyl)- 2- (4- sulfophenyl)- 2H- tetrazoliumIBA
10/2018 - 06/2007
2Biomarkers (Surrogate Marker)IBA
06/2018 - 01/2014
2Interleukin-17 (Interleukin 17)IBA
05/2018 - 01/2018
2beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA
01/2018 - 01/2016
2Adenosine (Adenocard)FDA LinkGeneric
01/2018 - 09/2004
2angelicinIBA
01/2017 - 09/2003
2InterleukinsIBA
01/2017 - 03/2011
2EnzymesIBA
12/2016 - 11/2006
2MethyltransferasesIBA
05/2016 - 08/2015
2AntagomirsIBA
05/2016 - 03/2016
2IronIBA
05/2016 - 06/2007
2Hormones (Hormone)IBA
01/2015 - 10/2002
2Member 1 Subfamily B ATP Binding Cassette TransporterIBA
01/2015 - 12/2012
2Cisplatin (Platino)FDA LinkGeneric
05/2014 - 09/2003

Therapy/Procedure

36Therapeutics
05/2022 - 05/2003
4Precision Medicine
01/2022 - 01/2019
3Drug Therapy (Chemotherapy)
05/2016 - 01/2015
2Investigational Therapies (Experimental Therapy)
11/2019 - 04/2012
2Traditional Medicine (Folk Remedies)
01/2017 - 01/2008
2Blood Transfusion (Blood Transfusions)
05/2016 - 11/2009